- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: August 2013
- Public Summary Document (PSD) August 2013 PBAC Meeting - PDF
Sunitinib – August 2013
Sunitinib, capsule, 12,5 mg, 25 mg, 50 mg (as malate), Sutent®
Last updated
8 November 2023